MyFinsight
Home
Blog
About
Contact
Download
Download image
Innovative Medicine
$15,426M
(11.19%↑ Y/Y)
Med Tech
$8,636M
(7.68%↑ Y/Y)
Sales to customers
(note 9)
$24,062M
(9.91%↑ Y/Y)
Gross profit
$15,956M
(9.77%↑ Y/Y)
Interest income
$229M
(-31.02%↓ Y/Y)
Cost of products sold
$8,106M
(10.18%↑ Y/Y)
Earnings before
provision for taxes on...
$5,990M
(-56.06%↓ Y/Y)
Selling, marketing and
administrative expenses
$6,034M
(18.04%↑ Y/Y)
Research and development
expense
$3,527M
(9.36%↑ Y/Y)
Other (income)
expense, net
-$294M
(-104.02%↓ Y/Y)
Interest expense, net of
portion capitalized
$272M
(33.33%↑ Y/Y)
In-process research and
development impairments
$36M
Restructuring (note 12)
$32M
(88.24%↑ Y/Y)
Net earnings
$5,235M
(-52.40%↓ Y/Y)
Provision for taxes on
income (note5)
$755M
(-71.31%↓ Y/Y)
Back
Back
Income Statement
JNJ_BIG_BIG copy-svg
JOHNSON & JOHNSON (JNJ)
JNJ_BIG_BIG copy-svg
source: myfinsight.com
JOHNSON & JOHNSON (JNJ)